Longview International Holdings is a Singapore-based holding company focusing on providing consulting and research services to life sciences companies, and associated investment entities.

The aim is to implement various medical research and development projects for the betterment of mankind by utilizing market capitalization. By successfully executing various medical projects, it will bring about a new sense of hope to patients suffering from severe illnesses, increase overall life expectancy, as well as improve the quality of life for all.

Our mission is to support and popularize academic research and development in the field of general health so that we can offer more effective treatments for all. Our subsidiaries in Singapore will focus their efforts on directing much-needed funding to more targeted medicines and treatments based on a variety of gene types, but with a particular focus on Asian genes. We will also set aside some of our resources for charitable funds so that the disenfranchised can have access to the same medical treatment.

With our unique access, we are able to perpetuate the world’s cutting-edge medical technology teams at leading research institutes in the United States, alongside renowned investment authorities on Wall Street, so as to fund various investment projects in the life sciences sector.

Under the leadership of our internationally-acclaimed advisors, and in partnership with select research institutes, we will fund and incubate various core R & D and critical illness technologies. As a result of in-depth medical research on academic implementation, these technologies will be introduced into the market for further development and commercialization.